What is Medtronic's SG&A?

Medtronic (MDT) reported SG&A of $3.06B in Q1 2026.

How has Medtronic's SG&A changed year-over-year?

Medtronic's SG&A increased by 12.4% year-over-year, from $2.72B to $3.06B.

What is the long-term trend for Medtronic's SG&A?

Over 4 years (2022 to 2026), Medtronic's SG&A has grown at a 3.4% compound annual growth rate (CAGR), from $10.29B to $11.78B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Medtronic MDT SG&A

SG&A at other companies

AbbottABT

$3.74B+22.2%

TFX

TeleflexTFX

$226.01M+47.8%

Johnson & JohnsonJNJ

$6.03B+18.0%

StrykerSYK

$2.28B-0.8%

CONMEDCNMD

$141.7M-4.8%

Merit Medical SystemsMMSI

$118.21M+10.0%

Segments

By segment

See full

Cardiovascular$1.19B+17.4%

Neuroscience$875M+7.6%

Medical Surgical$650M+9.6%

Diabetes$300M+12.8%

By product

See full

Shipping and Handling$336M+4.3%

Other financials

Income statement

See full

Revenue$9.8B+9.9%

Gross profit$6.4B+10.9%

Operating income$1.9B+30.4%

Net income$1.2B+17.8%

EPS (diluted)$0.97+18.3%

Balance sheet

See full

Cash & equivalents$1.9B-12.1%

Total debt$29.2B-1.6%

Total equity$49.5B+3.0%

Total assets$93.0B+1.5%

Cash flow

See full

Operating cash flow$2.6B+1.8%

CapEx$488.0M+6.3%

Free cash flow$2.1B+0.8%

Valuation

See full

Market cap$103.66B-9.1%

Enterprise value$130.92B-7.4%

P/E21.6×-2.9×

P/S2.9×-0.5×

Profitability

See full

Gross margin65%-0.3pp

Operating margin17.8%0.0pp

Net margin13.2%-0.7pp

FCF margin14.9%-0.5pp

Returns & leverage

See full

Return on equity9.8%+0.4pp

Debt / equity0.6×0.0×

Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medtronic's SG&A?: Medtronic (MDT) reported SG&A of $3.06B in Q1 2026.
How has Medtronic's SG&A changed year-over-year?: Medtronic's SG&A increased by 12.4% year-over-year, from $2.72B to $3.06B.
What is the long-term trend for Medtronic's SG&A?: Over 4 years (2022 to 2026), Medtronic's SG&A has grown at a 3.4% compound annual growth rate (CAGR), from $10.29B to $11.78B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.